These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 33176854

  • 1. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
    Alafate W, Xu D, Wu W, Xiang J, Ma X, Xie W, Bai X, Wang M, Wang J.
    J Exp Clin Cancer Res; 2020 Nov 11; 39(1):239. PubMed ID: 33176854
    [Abstract] [Full Text] [Related]

  • 2. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J.
    Life Sci; 2019 Nov 01; 236():116917. PubMed ID: 31614149
    [Abstract] [Full Text] [Related]

  • 3. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z, Zhang J, Zheng H, Li C, Xiong J, Wang W, Bao H, Jin H, Liang P.
    J Exp Clin Cancer Res; 2019 Aug 28; 38(1):380. PubMed ID: 31462285
    [Abstract] [Full Text] [Related]

  • 4. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 28; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 5. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.
    Alafate W, Wang M, Zuo J, Wu W, Sun L, Liu C, Xie W, Wang J.
    Pathol Res Pract; 2019 Nov 28; 215(11):152617. PubMed ID: 31563286
    [Abstract] [Full Text] [Related]

  • 6. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N.
    J Exp Clin Cancer Res; 2019 Jun 18; 38(1):266. PubMed ID: 31215502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W, Yan D, Song Z, Zhu X, Liu X, Li X, Zhao S.
    Life Sci; 2019 Jun 01; 226():98-106. PubMed ID: 30980849
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C, Guo R, Guan F, Ma S, Li M, Wu J, Liu X, Li H, Yang B.
    Sci Rep; 2020 Jun 11; 10(1):9471. PubMed ID: 32528036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
    Hersh DS, Harder BG, Roos A, Peng S, Heath JE, Legesse T, Kim AJ, Woodworth GF, Tran NL, Winkles JA.
    Neuro Oncol; 2018 Sep 03; 20(10):1321-1330. PubMed ID: 29897522
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway.
    Lan Y, Lou J, Hu J, Yu Z, Lyu W, Zhang B.
    Cancer Biol Med; 2020 Feb 15; 17(1):112-131. PubMed ID: 32296580
    [Abstract] [Full Text] [Related]

  • 14. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A, Wei Z, Yan W, Yin J, Huang X, Zhou X, Li R, Shen F, Wu W, Wang X, You Y.
    Cancer Lett; 2018 Nov 01; 436():10-21. PubMed ID: 30102952
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
    Peng Y, He X, Chen H, Duan H, Shao B, Yang F, Li H, Yang P, Zeng Y, Zheng J, Li Y, Hu J, Lin L, Teng L.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30061180
    [Abstract] [Full Text] [Related]

  • 16. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J, Zeng A, Zhang Z, Shi Z, Yan W, You Y.
    EBioMedicine; 2019 Apr 31; 42():238-251. PubMed ID: 30917935
    [Abstract] [Full Text] [Related]

  • 17. PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.
    Zhang Z, Wang Z, Huang K, Liu Y, Wei C, Zhou J, Zhang W, Wang Q, Liang H, Zhang A, Wang G, Zhen Y, Han L.
    Cancer Lett; 2019 Feb 28; 443():91-107. PubMed ID: 30529153
    [Abstract] [Full Text] [Related]

  • 18. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
    Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, Chen L, Lyu X, Shi Z, Yan W, You Y.
    Mol Cancer; 2020 Feb 10; 19(1):28. PubMed ID: 32039732
    [Abstract] [Full Text] [Related]

  • 19. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH, Cheng CH, Chou CM, Chen PH, Liu AJ, Lin CW, Shih CM, Chen KC.
    Pharmacol Res; 2019 Sep 10; 147():104390. PubMed ID: 31398406
    [Abstract] [Full Text] [Related]

  • 20. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
    Lee CAA, Banerjee P, Wilson BJ, Wu S, Guo Q, Berg G, Karpova S, Mishra A, Lian JW, Tran J, Emmerich M, Murphy GF, Frank MH, Frank NY.
    J Biol Chem; 2020 May 29; 295(22):7774-7788. PubMed ID: 32317280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.